-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Athira Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q3 2019 to Q3 2025.
- Athira Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1.41M, a 52% decline year-over-year.
- Athira Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $6.87M, a 37.8% decline year-over-year.
- Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $11M, a 4.01% increase from 2023.
- Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6M, a 0.16% increase from 2022.
- Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.6M, a 129% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)